{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:37:11Z","timestamp":1784432231779,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["NIHR129819"],"award-info":[{"award-number":["NIHR129819"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Asthma affects over 1 million children across the UK, and preventative treatment is guided subjectively by patient symptoms. Spirometry is an objective test of lung function and can be used in children to guide treatment. However, current guidelines do not indicate how asthma treatment should change in the context of changing spirometry results. This study will evaluate how spirometry can be used to guide asthma treatment and reduce the risk for asthma attacks in children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a multi-centre, randomised controlled trial. Children aged 6\u201315\u00a0years, who have a diagnosis of asthma and have had an exacerbation requiring oral or intravenous corticosteroids in the previous 12\u00a0months, will be eligible. Exclusion criteria include being unable to provide spirometry measurement at baseline assessment, having another chronic respiratory condition and being currently treated with maintenance oral steroids or biologicals. Participants will be recruited in both primary and secondary care settings and will be randomised to either receive asthma treatment guided by spirometry plus symptoms (intervention group) or asthma treatment guided by symptoms only (standard care group). Within the spirometry group, treatment recommendations will be dependent on changes in spirometry measurements. Participants will attend assessments 3, 6, 9 and 12\u00a0months post-randomisation, where treatment recommendations will be made. The primary outcome is the number of asthma attacks per participant requiring treatment with 1\u20137\u00a0days of oral or intravenous corticosteroid over 12\u00a0months, as recorded by the participant or parent. Secondary outcomes include time to first attack, any asthma attack, adverse events, dose of inhaled corticosteroids, asthma control and quality of life. Adherence to inhaled corticosteroid treatment is measured by an electronic logging device.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This study will evaluate whether asthma treatment guided by spirometry will reduce future asthma attacks in children. Our findings may be relevant to national and international asthma guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ISRCTN, ISRCTN31849868. Registered on 01.07.2022. Prospectively registered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-09104-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:43:10Z","timestamp":1759156990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spirometry to manage asthma in children: study protocol for a randomised controlled trial (SPIROMAC)"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-9296","authenticated-orcid":false,"given":"Victoria","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-0282","authenticated-orcid":false,"given":"Nicole","family":"Sergenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7883-0608","authenticated-orcid":false,"given":"Seonaidh","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1060-9963","authenticated-orcid":false,"given":"Chukwuemeka David","family":"Emele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8316-2616","authenticated-orcid":false,"given":"Ruth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-7972","authenticated-orcid":false,"given":"Lorna","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-8823","authenticated-orcid":false,"given":"Mark","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0996-8133","authenticated-orcid":false,"given":"Erol A.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-1161","authenticated-orcid":false,"given":"Erika J.","family":"Kennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-5646","authenticated-orcid":false,"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-5523","authenticated-orcid":false,"given":"Ian","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-6289","authenticated-orcid":false,"given":"Thenmalar","family":"Vadiveloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8067-9660","authenticated-orcid":false,"given":"Neil W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8393-5060","authenticated-orcid":false,"given":"Steve","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"9104_CR1","unstructured":"Asthma UK. Asthma facts and FAQs. 2020; Available at: https:\/\/www.asthma.org.uk\/about\/media\/facts-and-statistics\/. Accessed 04\/12, 2020."},{"issue":"6","key":"9104_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/thx.44.6.474","volume":"44","author":"DP Strachan","year":"1989","unstructured":"Strachan DP. Repeatability of ventilatory function measurements in a population survey of 7 year old children. Thorax. 1989;44(6):474\u20139.","journal-title":"Thorax"},{"issue":"2","key":"9104_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/thoraxjnl-2019-213068","volume":"75","author":"DK Lo","year":"2020","unstructured":"Lo DK, Beardsmore CS, Roland D, Richardson M, Yang Y, Danvers L, et al. Lung function and asthma control in school-age children managed in UK primary care: a cohort study. Thorax. 2020;75(2):101\u20137.","journal-title":"Thorax"},{"key":"9104_CR4","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. https:\/\/ginasthma.org\/gina-reports\/. Updated 2019. Accessed 07\/26, 2019."},{"issue":"1","key":"9104_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1067\/mai.2001.111590","volume":"107","author":"AL Fuhlbrigge","year":"2001","unstructured":"Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001;107(1):61\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"9104_CR6","unstructured":"National Institute for Health and Care Excellence. Asthma: Diagnosis, monitoring and chronic asthma management. https:\/\/www.nice.org.uk\/guidance\/ng80. Updated 2017. Accessed 01\/28, 2018."},{"issue":"8","key":"9104_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1398-9995.2012.02865.x","volume":"67","author":"NG Papadopoulos","year":"2012","unstructured":"Papadopoulos NG, Arakawa H, Carlsen K, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976\u201397.","journal-title":"Allergy"},{"key":"9104_CR8","unstructured":"National, Asthma Education and Prevention Program Expert panel report 3\u2014Guidelines for the diagnosis and management of asthma. https:\/\/www.nhlbi.nih.gov\/files\/docs\/guidelines\/asthsumm.pdf. Updated 2007. Accessed 01\/02, 2018."},{"key":"9104_CR9","unstructured":"British Thoracic Society and Scottish Intercollegiate Guidelines Network. SIGN 158. The British guideline on the management of asthma. https:\/\/www.brit-thoracic.org.uk\/quality-improvement\/guidelines\/asthma\/. Updated 2019. Accessed 07\/27, 2019."},{"key":"9104_CR10","unstructured":"NICE (National Institute for Health and Care Excellence). Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN). https:\/\/www.nice.org.uk\/guidance\/ng245. Updated 2024. Accessed 04\/03, 2025"},{"issue":"1","key":"9104_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.mcp.0000198065.65704.08","volume":"12","author":"HK Reddel","year":"2006","unstructured":"Reddel HK. Peak flow monitoring in clinical practice and clinical asthma trials. Curr Opin Pulm Med. 2006;12(1):75\u201381.","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"9104_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.chest.2018.10.009","volume":"155","author":"S Fielding","year":"2019","unstructured":"Fielding S, Pijnenburg M, de Jongste JC, Pike KC, Roberts G, Petsky H, et al. Change in FEV(1) and Feno measurements as predictors of future asthma outcomes in children. Chest. 2019;155(2):331\u201341.","journal-title":"Chest"},{"issue":"6","key":"9104_CR13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jaci.2014.12.1942","volume":"135","author":"SJ Teach","year":"2015","unstructured":"Teach SJ, Gergen PJ, Szefler SJ, Mitchell HE, Calatroni A, Wildfire J, et al. Seasonal risk factors for asthma exacerbations among inner-city children. J Allergy Clin Immunol. 2015Jun;135(6):1465-73.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9104_CR14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1378\/chest.126.6.1875","volume":"126","author":"BT Kitch","year":"2004","unstructured":"Kitch BT, Paltiel AD, Kuntz KM, Dockery DW, Schouten JP, Weiss ST, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest. 2004;126(6):1875\u201382.","journal-title":"Chest"},{"issue":"5","key":"9104_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jaci.2012.08.009","volume":"130","author":"AC Wu","year":"2012","unstructured":"Wu AC, Gregory M, Kymes S, Lambert D, Edler J, Stwalley D, et al. Modeling asthma exacerbations through lung function in children. J Allergy Clin Immunol. 2012;130(5):1065\u201370.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9104_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1164\/rccm.200308-1178OC","volume":"170","author":"LB Bacharier","year":"2004","unstructured":"Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RFJ, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004Aug 15;170(4):426\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10118","key":"9104_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","volume":"391","author":"ID Pavord","year":"2018","unstructured":"Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350\u2013400.","journal-title":"Lancet"},{"key":"9104_CR18","doi-asserted-by":"crossref","unstructured":"Turner SW. Uncertain role of spirometry in managing childhood asthma in the UK 2019. Arch Dis Child 2020 Sep;105(9):914. Epub 2019 Jul 3.","DOI":"10.1136\/archdischild-2019-317781"},{"issue":"8 Pt 1","key":"9104_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1164\/ajrccm.164.8.2101145","volume":"164","author":"DN Payne","year":"2001","unstructured":"Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001Oct 15;164(8 Pt 1):1376\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"9104_CR20","unstructured":"SPIROMAC Study website; Available at: https:\/\/w3.abdn.ac.uk\/hsru\/SPIROMAC\/Public\/Public\/index.cshtml. Accessed 04\/03, 2025"},{"key":"9104_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s13063-019-3500-7","volume":"20","author":"S Turner","year":"2019","unstructured":"Turner S, Cotton SC, Emele CD, et al. Reducing asthma attacks in children using exhaled nitric oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO). Trials. 2019;20:573. https:\/\/doi.org\/10.1186\/s13063-019-3500-7.","journal-title":"Trials"},{"issue":"1","key":"9104_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280086","volume":"18","author":"L Lawrie","year":"2023","unstructured":"Lawrie L, Turner S, Cotton SC, Wood J, Morgan HM. A qualitative process evaluation within a clinical trial that used healthcare technologies for children with asthma-insights and implications. PLoS ONE. 2023Jan 5;18(1):e0280086.","journal-title":"PLoS ONE"},{"issue":"3","key":"9104_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1164\/rccm.200708-1248OC","volume":"177","author":"S Stanojevic","year":"2008","unstructured":"Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008Feb 1;177(3):253\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"9104_CR24","doi-asserted-by":"crossref","unstructured":"Turner S, Filipow N, Vermeulan F, Vael R, Frischer T, Changg A, Petsky H, Szefler S, Stanojevic S. How much change in FEV1 is associated with an increased risk of an asthma exacerbation? European Respiratory Society ;62(suppl 67):OA1436.","DOI":"10.1183\/13993003.congress-2023.OA1436"},{"key":"9104_CR25","doi-asserted-by":"crossref","unstructured":"Filipow N, Turner S, Petsky HL, Chang AB, Frischer T, Szefler S, et al. Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthmaThorax 2024 Nov 14;79(12):1145\u20131150.","DOI":"10.1136\/thorax-2024-221755"},{"issue":"3","key":"9104_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","volume":"117","author":"M Schatz","year":"2006","unstructured":"Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549\u201356.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9104_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00435967","volume":"5","author":"EF Juniper","year":"1996","unstructured":"Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996;5(1):35\u201346.","journal-title":"Qual Life Res"},{"key":"9104_CR28","doi-asserted-by":"crossref","unstructured":"Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applicationsAm J Respir Crit Care Med 2011 Sep 1;184(5):602\u2013615.","DOI":"10.1164\/rccm.9120-11ST"},{"issue":"24","key":"9104_CR29","first-page":"4828","volume":"38","author":"S Vansteelandt","year":"2019","unstructured":"Vansteelandt S, Linder M, Vandenberghe S, Steen J, Madsen J. Mediation analysis of time-to-event endpoints accounting for repeatedly measured mediators subject to time-varying confoundingStat Med. 2019Oct 30;38(24):4828\u201340.","journal-title":"Mediation analysis of time-to-event endpoints accounting for repeatedly measured mediators subject to time-varying confoundingStat Med"},{"key":"9104_CR30","unstructured":"NIHR Funding and Awards website; Available at: https:\/\/www.fundingawards.nihr.ac.uk\/. Accessed 04\/04, 2025."},{"issue":"2","key":"9104_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"key":"9104_CR32","unstructured":"Johnson D, Sergenson N, Bell V, Constable L, Wileman S. Site evaluations of trial training and recommendations for practice. ICTMC 2024 Abstract Book;121."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09104-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:43:13Z","timestamp":1759156993000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09104-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9104"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09104-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has ethical approval from West Midlands\u2014Black Country Research Ethics Committee (22\/WM\/0097), and central and local NHS R&D approvals have been obtained. The study is co-sponsored by the University of Aberdeen and NHS Grampian. Consent is obtained from parents\/carers, and (where appropriate) from the child. If the child does not provide written consent, they are asked to give verbal assent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable since there are no identifying images or other personal or clinical details of participants presented. Informed consent materials are available from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"All authors report grant funding paid to their institution from NIHR\/MRC (Efficacy and Mechanism Evaluation, NIHR129819) for the SPIROMAC trial. EAG also reports investigator-led research grants from Gilead Sciences, Chiesi Limited and Propeller Health; research collaboration with Astra Zeneca, Helicon Health and Adherium (NZ) Limited; and speaker fees from Circassia Group and Sanofi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"373"}}